Autopsy report · NCT01963715
A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid Tumors
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 6 months before it stopped.
- 20 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- ImmunoGen, Inc.
- Sponsor type
- Industry
- Conditions
- EGFR Positive Solid Tumors
- Interventions
- IMGN289
- Participants
- 20
- Sites
- 4
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.